Palvella

$Palvella(PVLA)$ 这么好的适应症，这么平平无奇的药物，牛逼的转化和制剂思路。。。低调的十倍股

#药闻简讯# $Palvella(PVLA)$ 公司研发的 QTORIN 3.9%雷帕霉素无水凝胶获得 FDA 快速通道资格认定，用于治疗血管角化瘤

#药闻简讯# $Palvella(PVLA)$ 宣布 QTORIN 3.9% 环孢素胶用于治疗皮肤静脉畸形（一种严重且罕见的遗传性疾病，目前尚无 FDA 批准的疗法）的 II 期 TOIVA 临床试验取得积极顶线结果

$Palvella(PVLA)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-25-274378  Act: 34  Size: 9 MB 网页链接

$Palvella(PVLA)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000919574-25-006758  Act: 34  Size: 17 KB 网页链接

$Palvella(PVLA)$ 144 Report of proposed sale of securities Accession Number: 0001967940-25-000085  Act: 33  Size: 4 KB 网页链接

$Palvella(PVLA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-276119  Act: 34  Size: 7 MB 网页链接

$Palvella(PVLA)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001104659-25-092681  Act: 34  Size: 257 KB 网页链接

$Palvella(PVLA)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-106591  Act: 34  Size: 4 MB 网页链接

$Palvella(PVLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-115017  Size: 15 KB 网页链接

$Palvella(PVLA)$ 144 Report of proposed sale of securities Accession Number: 0001967940-25-000095  Act: 33  Size: 5 KB 网页链接

$Palvella(PVLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-123109  Size: 13 KB 网页链接

$Palvella(PVLA)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000921895-25-003114  Act: 34  Size: 25 KB 网页链接

$Palvella(PVLA)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-120789  Act: 34  Size: 2 MB 网页链接